1. Home
  2. ANPA vs ABVX Comparison

ANPA vs ABVX Comparison

Compare ANPA & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANPA
  • ABVX
  • Stock Information
  • Founded
  • ANPA 2016
  • ABVX 2013
  • Country
  • ANPA Hong Kong
  • ABVX France
  • Employees
  • ANPA N/A
  • ABVX N/A
  • Industry
  • ANPA
  • ABVX
  • Sector
  • ANPA
  • ABVX
  • Exchange
  • ANPA Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • ANPA 465.1M
  • ABVX 5.3B
  • IPO Year
  • ANPA 2025
  • ABVX N/A
  • Fundamental
  • Price
  • ANPA $42.00
  • ABVX $81.03
  • Analyst Decision
  • ANPA
  • ABVX Buy
  • Analyst Count
  • ANPA 0
  • ABVX 7
  • Target Price
  • ANPA N/A
  • ABVX $74.86
  • AVG Volume (30 Days)
  • ANPA 43.3K
  • ABVX 1.1M
  • Earning Date
  • ANPA 01-01-0001
  • ABVX 08-11-2025
  • Dividend Yield
  • ANPA N/A
  • ABVX N/A
  • EPS Growth
  • ANPA 1.75
  • ABVX N/A
  • EPS
  • ANPA 0.07
  • ABVX N/A
  • Revenue
  • ANPA $5,884,401.00
  • ABVX $11,444,012.00
  • Revenue This Year
  • ANPA N/A
  • ABVX $25.23
  • Revenue Next Year
  • ANPA N/A
  • ABVX N/A
  • P/E Ratio
  • ANPA $620.43
  • ABVX N/A
  • Revenue Growth
  • ANPA N/A
  • ABVX 128.98
  • 52 Week Low
  • ANPA $2.80
  • ABVX $4.77
  • 52 Week High
  • ANPA $54.75
  • ABVX $82.13
  • Technical
  • Relative Strength Index (RSI)
  • ANPA N/A
  • ABVX 82.18
  • Support Level
  • ANPA N/A
  • ABVX $78.00
  • Resistance Level
  • ANPA N/A
  • ABVX $78.49
  • Average True Range (ATR)
  • ANPA 0.00
  • ABVX 2.95
  • MACD
  • ANPA 0.00
  • ABVX -0.99
  • Stochastic Oscillator
  • ANPA 0.00
  • ABVX 92.66

About ANPA Rich Sparkle Holdings Limited Ordinary Shares

Rich Sparkle Holdings Ltd is financial printing and corporate services provider which engaged in designing and printing financial print materials in Hong Kong. It service portfolio covers a myriad of deliverables, mainly including listing documents, financial reports, fund documents, circulars and announcements. The company's core business includes (i) financial printing services such as printing, typesetting and translation, (ii) advisory services including Environmental, Social and Governance Report and (iii) other services. Key revenue is generated from Financial printing services.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: